The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.

<h4>Background</h4>Visceral Leishmaniasis (VL) is endemic in South Sudan, manifesting periodically in major outbreaks. Provision of treatment during endemic periods and as an emergency response is impeded by instability and conflict. Médecins Sans Frontières (MSF) has provided health car...

Full description

Bibliographic Details
Main Authors: Gabriel Naylor-Leyland, Simon M Collin, Francis Gatluak, Margriet den Boer, Fabiana Alves, Abdul Wasay Mullahzada, Koert Ritmeijer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-08-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0010696
_version_ 1798000694270099456
author Gabriel Naylor-Leyland
Simon M Collin
Francis Gatluak
Margriet den Boer
Fabiana Alves
Abdul Wasay Mullahzada
Koert Ritmeijer
author_facet Gabriel Naylor-Leyland
Simon M Collin
Francis Gatluak
Margriet den Boer
Fabiana Alves
Abdul Wasay Mullahzada
Koert Ritmeijer
author_sort Gabriel Naylor-Leyland
collection DOAJ
description <h4>Background</h4>Visceral Leishmaniasis (VL) is endemic in South Sudan, manifesting periodically in major outbreaks. Provision of treatment during endemic periods and as an emergency response is impeded by instability and conflict. Médecins Sans Frontières (MSF) has provided health care in South Sudan since the late 1980's, including treatment for 67,000 VL patients. In recent years, MSF monitoring data have indicated increasing numbers of VL relapse cases. A retrospective analysis of these data was performed in order to provide insight into the possible causes of this increase.<h4>Methodology/principal findings</h4>Programme monitoring data from the MSF hospital in Lankien, Jonglei State, South Sudan, for the period 2001-2018 were analysed to detect trends in VL relapse as a proportion of all VL cases presenting to MSF treatment centres. Routinely collected patient-level data from relapse and primary VL cases treated at all MSF sites in South Sudan over the same period were analysed to describe patient characteristics and treatments received. VL relapse as a proportion of all VL cases increased by 6.5% per annum (95% CI 0.3% to 13.0%, p = 0.04), from 5.2% during 2001-2003 to 14.4% during 2016-2018. Primary VL and VL relapse patients had similar age, sex and anthropometric characteristics, the latter indicating high indices of undernutrition which were relatively constant over time. Clinical factors (Hb, spleen size, and VL severity score) also did not vary substantially over time. SSG/PM was the main treatment regimen from 2001-2018, used in 68.7% of primary and 70.9% of relapse VL cases; AmBisome was introduced in 2013, received by 22.5% of primary VL and 32.6% of VL relapse cases from 2013-2018.<h4>Conclusion</h4>Increasing incidence of VL relapse in South Sudan does not appear to be explained by changes in patient characteristics or other factors. Our data are concerning and may indicate an emergence of treatment-resistant parasite strains, decreasing the effectiveness of treatment regimens. This warrants further investigation as a causal factor. New chemical entities that will enable safe and highly effective short-course oral treatments for VL are urgently needed.
first_indexed 2024-04-11T11:24:26Z
format Article
id doaj.art-02964974e159403fb06cbf32bbdf67d0
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-04-11T11:24:26Z
publishDate 2022-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-02964974e159403fb06cbf32bbdf67d02022-12-22T04:26:21ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352022-08-01168e001069610.1371/journal.pntd.0010696The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.Gabriel Naylor-LeylandSimon M CollinFrancis GatluakMargriet den BoerFabiana AlvesAbdul Wasay MullahzadaKoert Ritmeijer<h4>Background</h4>Visceral Leishmaniasis (VL) is endemic in South Sudan, manifesting periodically in major outbreaks. Provision of treatment during endemic periods and as an emergency response is impeded by instability and conflict. Médecins Sans Frontières (MSF) has provided health care in South Sudan since the late 1980's, including treatment for 67,000 VL patients. In recent years, MSF monitoring data have indicated increasing numbers of VL relapse cases. A retrospective analysis of these data was performed in order to provide insight into the possible causes of this increase.<h4>Methodology/principal findings</h4>Programme monitoring data from the MSF hospital in Lankien, Jonglei State, South Sudan, for the period 2001-2018 were analysed to detect trends in VL relapse as a proportion of all VL cases presenting to MSF treatment centres. Routinely collected patient-level data from relapse and primary VL cases treated at all MSF sites in South Sudan over the same period were analysed to describe patient characteristics and treatments received. VL relapse as a proportion of all VL cases increased by 6.5% per annum (95% CI 0.3% to 13.0%, p = 0.04), from 5.2% during 2001-2003 to 14.4% during 2016-2018. Primary VL and VL relapse patients had similar age, sex and anthropometric characteristics, the latter indicating high indices of undernutrition which were relatively constant over time. Clinical factors (Hb, spleen size, and VL severity score) also did not vary substantially over time. SSG/PM was the main treatment regimen from 2001-2018, used in 68.7% of primary and 70.9% of relapse VL cases; AmBisome was introduced in 2013, received by 22.5% of primary VL and 32.6% of VL relapse cases from 2013-2018.<h4>Conclusion</h4>Increasing incidence of VL relapse in South Sudan does not appear to be explained by changes in patient characteristics or other factors. Our data are concerning and may indicate an emergence of treatment-resistant parasite strains, decreasing the effectiveness of treatment regimens. This warrants further investigation as a causal factor. New chemical entities that will enable safe and highly effective short-course oral treatments for VL are urgently needed.https://doi.org/10.1371/journal.pntd.0010696
spellingShingle Gabriel Naylor-Leyland
Simon M Collin
Francis Gatluak
Margriet den Boer
Fabiana Alves
Abdul Wasay Mullahzada
Koert Ritmeijer
The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.
PLoS Neglected Tropical Diseases
title The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.
title_full The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.
title_fullStr The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.
title_full_unstemmed The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.
title_short The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.
title_sort increasing incidence of visceral leishmaniasis relapse in south sudan a retrospective analysis of field patient data from 2001 2018
url https://doi.org/10.1371/journal.pntd.0010696
work_keys_str_mv AT gabrielnaylorleyland theincreasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018
AT simonmcollin theincreasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018
AT francisgatluak theincreasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018
AT margrietdenboer theincreasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018
AT fabianaalves theincreasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018
AT abdulwasaymullahzada theincreasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018
AT koertritmeijer theincreasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018
AT gabrielnaylorleyland increasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018
AT simonmcollin increasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018
AT francisgatluak increasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018
AT margrietdenboer increasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018
AT fabianaalves increasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018
AT abdulwasaymullahzada increasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018
AT koertritmeijer increasingincidenceofvisceralleishmaniasisrelapseinsouthsudanaretrospectiveanalysisoffieldpatientdatafrom20012018